focus -WSS

focus

author：entertainment 2025-10-02 18:47:52 - browse：64279

John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT — John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Surge in Apellis stock fueled by confidence in safety of its eye drug

hotspot

WSS

It costs an awful lot of money to give away a kidney

Be careful with at

FDA approves Sage Therapeutics’ rapid

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

FDA approves Sage Therapeutics’ rapid

Aspartame and sugar

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Study links childhood stress with decline in older age

Guidelines to prevent youth baseball injuries need more muscle

Aspartame and sugar

DIEP, the 'gold standard' of breast reconstruction, is under threat

'Null' research findings aren't empty of meaning. Let's publish them

Walensky prepares to leave CDC — and Congress — behind

Late stage cancers on the rise after pandemic delayed screenings

Hepatitis C has a cure — but many Americans still lack access to it

Patients, digital health players weigh in on FTC's data privacy plan

focus

Illumina slashes 2023 revenue projections yet again

Flint parents haunted by uncertainty, fears of lead poisoning

Bird flu researchers hone in on Finland’s mink farms

Treatments for cramps don't cut it. Why aren't there better options?

Megan Rapinoe shares emotional post following US Women's World Cup exit

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

hotspot

hotspot

focus